|
1
|
Clementini M, Rossetti PH, Penarrocha D,
Micarelli C, Bonachela WC and Canullo L: Systemic risk factors for
peri-implant bone loss: A systematic review and meta-analysis. Int
J Oral Maxillofac Surg. 43:323–334. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Nemtoi A, Ladunca O, Dragan E, Budacu C,
Mihai C and Haba D: Quantitative and qualitative bone assessment of
the posterior mandible in patients with diabetes mellitus: A cone
beam computed tomography study. Rev Med Chir Soc Med Nat Iasi.
117:1002–1008. 2013.
|
|
3
|
de Morais JA, Trindade-Suedam IK, Pepato
MT, Marcantonio E Jr, Wenzel A and Scaf G: Effect of diabetes
mellitus and insulin therapy on bone density around osseointegrated
dental implants: A digital subtraction radiography study in rats.
Clin Oral Implants Res. 20:796–801. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Dobreva G, Chahrour M, Dautzenberg M,
Chirivella L, Kanzler B, Fariñas I, Karsenty G and Grosschedl R:
SATB2 is a multifunctional determinant of craniofacial patterning
and osteoblast differentiation. Cell. 125:971–986. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Liu Q and Paroo Z: Biochemical principles
of small RNA pathways. Annu Rev Biochem. 79:295–319. 2010.
View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ha M and Kim VN: Regulation of microRNA
biogenesis. Nat Rev Mol Cell Biol. 15:509–524. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Zhang Y, Xie RL, Gordon J, LeBlanc K,
Stein JL, Lian JB, van Wijnen AJ and Stein GS: Control of
mesenchymal lineage progression by microRNAs targeting skeletal
gene regulators Trps1 and Runx2. J Biol Chem. 287:21926–21935.
2012. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Li Z, Hassan MQ, Volinia S, van Wijnen AJ,
Stein JL, Croce CM, Lian JB and Stein GS: A microRNA signature for
a BMP2-induced osteoblast lineage commitment program. Proc Natl
Acad Sci USA. 105:13906–13911. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Liu H, Sun Q, Wan C, Li L, Zhang L and
Chen Z: MicroRNA-338-3p regulates osteogenic differentiation of
mouse bone marrow stromal stem cells by targeting Runx2 and Fgfr2.
J Cell Physiol. 229:1494–1502. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Kim EJ, Kang IH, Lee JW, Jang WG and Koh
JT: MiR-433 mediates ERRγ-suppressed osteoblast differentiation via
direct targeting to Runx2 mRNA in C3H10T1/2 cells. Life Sci.
92:562–568. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Zuo B, Zhu J, Li J, Wang C, Zhao X, Cai G,
Li Z, Peng J, Wang P, Shen C, et al: microRNA-103a functions as a
mechanosensitive microRNA to inhibit bone formation through
targeting Runx2. J Bone Miner Res. 30:330–345. 2015. View Article : Google Scholar
|
|
12
|
Tomé M, López-Romero P, Albo C, Sepúlveda
JC, Fernández- Gutiérrez B, Dopazo A, Bernad A and González MA:
miR-335 orchestrates cell proliferation, migration and
differentiation in human mesenchymal stem cells. Cell Death Differ.
18:985–995. 2011. View Article : Google Scholar :
|
|
13
|
Jia J, Tian Q, Ling S, Liu Y, Yang S and
Shao Z: miR-145 suppresses osteogenic differentiation by targeting
Sp7. FEBS Lett. 587:3027–3031. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Shi K, Lu J, Zhao Y, Wang L, Li J, Qi B,
Li H and Ma C: MicroRNA-214 suppresses osteogenic differentiation
of C2C12 myoblast cells by targeting Osterix. Bone. 55:487–494.
2013. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Baglìo SR, Devescovi V, Granchi D and
Baldini N: MicroRNA expression profiling of human bone marrow
mesenchymal stem cells during osteogenic differentiation reveals
Osterix regulation by miR-31. Gene. 527:321–331. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Goettsch C, Rauner M, Pacyna N, Hempel U,
Bornstein SR and Hofbauer LC: miR-125b regulates calcification of
vascular smooth muscle cells. Am J Pathol. 179:1594–1600. 2011.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Chen S, Yang L, Jie Q, Lin YS, Meng GL,
Fan JZ, Zhang JK, Fan J, Luo ZJ and Liu J: MicroRNA-125b suppresses
the proliferation and osteogenic differentiation of human bone
marrow-derived mesenchymal stem cells. Mol Med Rep. 9:1820–1826.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang JF, Fu WM, He ML, Wang H, Wang WM,
Yu SC, Bian XW, Zhou J, Lin MC, Lu G, et al: miR-637 maintains the
balance between adipocytes and osteoblasts by directly targeting
Osterix. Mol Biol Cell. 22:3955–3961. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Itoh T, Nozawa Y and Akao Y: MicroRNA-141
and -200a are involved in bone morphogenetic protein-2-induced
mouse pre-osteoblast differentiation by targeting distal-less
homeobox 5. J Biol Chem. 284:19272–19279. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Xie Q, Wang Z, Bi X, Zhou H, Wang Y, Gu P
and Fan X: Effects of miR-31 on the osteogenesis of human
mesenchymal stem cells. Biochem Biophys Res Commun. 446:98–104.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Li J, Dong J, Zhang ZH, Zhang DC, You XY,
Zhong Y, Chen MS and Liu SM: miR-10a restores human mesenchymal
stem cell differentiation by repressing KLF4. J Cell Physiol.
228:2324–2336. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Li Z, Hassan MQ, Jafferji M, Aqeilan RI,
Garzon R, Croce CM, van Wijnen AJ, Stein JL, Stein GS and Lian JB:
Biological functions of miR-29b contribute to positive regulation
of osteoblast differentiation. J Biol Chem. 284:15676–15684. 2009.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Lin EA, Kong L, Bai XH, Luan Y and Liu CJ:
miR-199a, a bone morphogenic protein 2-responsive MicroRNA,
regulates chondrogenesis via direct targeting to Smad1. J Biol
Chem. 284:11326–11335. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Kureel J, Dixit M, Tyagi AM, Mansoori MN,
Srivastava K, Raghuvanshi A, Maurya R, Trivedi R, Goel A and Singh
D: miR-542-3p suppresses osteoblast cell proliferation and
differentiation, targets BMP-7 signaling and inhibits bone
formation. Cell Death Dis. 5:e10502014. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Luzi E, Marini F, Sala SC, Tognarini I,
Galli G and Brandi ML: Osteogenic differentiation of human adipose
tissue-derived stem cells is modulated by the miR-26a targeting of
the SMAD1 transcription factor. J Bone Miner Res. 23:287–295. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Zheng L, Tu Q, Meng S, Zhang L, Yu L, Song
J, Hu Y, Sui L, Zhang J, Dard M, et al: Runx2/DICER/miRNA pathway
in regulating osteogenesis. J Cell Physiol. 232:182–191. 2017.
View Article : Google Scholar
|
|
27
|
Ko JY, Chuang PC, Chen MW, Ke HC, Wu SL,
Chang YH, Chen YS and Wang FS: MicroRNA-29a ameliorates
gluco-corticoid-induced suppression of osteoblast differentiation
by regulating β-catenin acetylation. Bone. 57:468–475. 2013.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Wang T and Xu Z: miR-27 promotes
osteoblast differentiation by modulating Wnt signaling. Biochem
Biophys Res Commun. 402:186–189. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Hassan MQ, Maeda Y, Taipaleenmaki H, Zhang
W, Jafferji M, Gordon JA, Li Z, Croce CM, van Wijnen AJ, Stein JL,
et al: miR-218 directs a Wnt signaling circuit to promote
differentiation of osteoblasts and osteomimicry of metastatic
cancer cells. J Biol Chem. 287:42084–42092. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Clark EA, Kalomoiris S, Nolta JA and
Fierro FA: Concise review: MicroRNA function in multipotent
mesenchymal stromal cells. Stem cells. 32:1074–1082. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Gaur T, Hussain S, Mudhasani R, Parulkar
I, Colby JL, Frederick D, Kream BE, van Wijnen AJ, Stein JL, Stein
GS, et al: Dicer inactivation in osteoprogenitor cells compromises
fetal survival and bone formation, while excision in differentiated
osteoblasts increases bone mass in the adult mouse. Dev Biol.
340:10–21. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Schmittgen TD and Livak KJ: Analyzing
real-time PCR data by the comparative C(T) method. Nat Protoc.
3:1101–1108. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Lu H, Kraut D, Gerstenfeld LC and Graves
DT: Diabetes interferes with the bone formation by affecting the
expression of transcription factors that regulate osteoblast
differentiation. Endocrinology. 144:346–352. 2003. View Article : Google Scholar
|
|
34
|
García-Hernández A, Arzate H,
Gil-Chavarria I, Rojo R and Moreno-Fierros L: High glucose
concentrations alter the biomineralization process in human
osteoblastic cells. Bone. 50:276–288. 2012. View Article : Google Scholar
|
|
35
|
Ogawa N, Yamaguchi T, Yano S, Yamauchi M,
Yamamoto M and Sugimoto T: The combination of high glucose and
advanced glycation end-products (AGEs) inhibits the mineralization
of osteoblastic MC3T3-E1 cells through glucose-induced increase in
the receptor for AGEs. Horm Metab Res. 39:871–875. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
36
|
Gopalakrishnan V, Vignesh RC, Arunakaran
J, Aruldhas MM and Srinivasan N: Effects of glucose and its
modulation by insulin and estradiol on BMSC differentiation into
osteoblastic lineages. Biochem Cell Biol. 84:93–101. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
37
|
van Rooij E: The art of microRNA research.
Circ Res. 108:219–234. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Wang JC: miR-467f modulates osteogenic
differentiation of mice bone mesenchymal stem cells in high glucose
environment. Military Medical School; Beijing: 2013, In
Chinese.
|
|
39
|
Yang Z, Zhong L, Zhong S, Xian R and Yuan
B: miR-203 protects microglia mediated brain injury by regulating
inflammatory responses via feedback to MyD88 in ischemia. Mol
Immunol. 65:293–301. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Okumura T, Shimada Y, Moriyama M, Takei Y,
Omura T, Sekine S, Nagata T, Shimizu K and Tsukada K: MicroRNA-203
inhibits the progression of esophageal squamous cell carcinoma with
restored epithelial tissue architectur in vivo. Int J Oncol.
44:1923–1932. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Yu X, Jiang X, Li H, Guo L, Jiang W and Lu
SH: miR-203 inhibits the proliferation and self-renewal of
esophageal cancer stem-like cells by suppressing stem renewal
factor Bmi-1. Stem Cells Dev. 23:576–585. 2014. View Article : Google Scholar
|
|
42
|
Delic D, Eisele C, Schmid R, Luippold G,
Mayoux E and Grempler R: Characterization of Micro-RNA changes
during the progression of type 2 diabetes in Zucker diabetic fatty
rats. Int J Mol Sci. 17:pii: E665. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Liu J, Xu Y, Shu B, Wang P, Tang J, Chen
L, Qi S, Liu X and Xie J: Quantification of the differential
expression levels of microRNA-203 in different degrees of diabetic
foot. Int J Clin Exp Pathol. 8:13416–13420. 2015.
|
|
44
|
Hoodless PA, Haerry T, Abdollah S,
Stapleton M, O'Connor MB, Attisano L and Wrana JL: MADR1, a
MAD-related protein that functions in BMP2 signaling pathways.
Cell. 85:489–500. 1996. View Article : Google Scholar : PubMed/NCBI
|
|
45
|
Wang M, Jin H, Tang D, Huang S, Zuscik MJ
and Chen D: Smad1 plays an essential role in bone development and
postnatal bone formation. Osteoarthritis Cartilage. 19:751–762.
2011. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Ehnert S, Freude T, Ihle C, Mayer L, Braun
B, Graeser J, Flesch I, Stöckle U, Nussler AK and Pscherer S:
Factors circulating in the blood of type 2 diabetes mellitus
patients affect osteoblast maturation-description of a novel in
vitro model. Exp Cell Res. 332:247–258. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Miyazono K, Maeda S and Imamura T:
Coordinate regulation of cell growth and differentiation by
TGF-beta superfamily and Runx proteins. Oncogene. 23:4232–4237.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Pfeilschifter J, Bonewald L and Mundy GR:
Characterization of the latent transforming growth factor beta
complex in bone. J Bone Miner Res. 5:49–58. 1990. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Edwards JR, Nyman JS, Lwin ST, Moore MM,
Esparza J, O'Quinn EC, Hart AJ, Biswas S, Patil CA, Lonning S, et
al: Inhibition of TGF-β signaling by 1D11 antibody treatment
increases bone mass and quality in vivo. J Bone Miner Res.
25:2419–2426. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Mohammad KS, Chen CG, Balooch G, Stebbins
E, McKenna CR, Davis H, Niewolna M, Peng XH, Nguyen DH,
Ionova-Martin SS, et al: Pharmacologic inhibition of the TGF-beta
type I receptor kinase has anabolic and anti-catabolic effects on
bone. PLoS One. 4:e52752009. View Article : Google Scholar : PubMed/NCBI
|
|
51
|
Matsumoto Y, Otsuka F, Hino J, Miyoshi T,
Takano M, Miyazato M, Makino H and Kangawa K: Bone morphogenetic
protein-3b (BMP-3b) inhibits osteoblast differentiation via Smad2/3
pathway by counteracting Smad1/5/8 signaling. Mol Cell Endocrinol.
350:78–86. 2012. View Article : Google Scholar
|
|
52
|
Taipaleenmaki H, Browne G, Akech J, Zustin
J, van Wijnen AJ, Stein JL, Hesse E, Stein GS and Lian JB:
Targeting of Runx2 by miR-135 and miR-203 impairs progression of
breast cancer and metastatic bone disease. Cancer Res.
75:1433–1444. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Saini S, Majid S, Yamamura S, Tabatabai L,
Suh SO, Shahryari V, Chen Y, Deng G, Tanaka Y and Dahiya R:
Regulatory Role of mir-203 in prostate cancer progression and
metastasis. Clin Cancer Res. 17:5287–5298. 2011. View Article : Google Scholar
|
|
54
|
Lee MH, Kwon TG, Park HS, Wozney JM and
Ryoo HM: BMP-2-induced Osterix expression is mediated by Dlx5 but
is independent of Runx2. Biochem Biophys Res Commun. 309:689–694.
2003. View Article : Google Scholar : PubMed/NCBI
|
